The relapsed or refractory diffuse large B-cell lymphoma market involves the treatment of lymphoma, which is a cancer that begins in lymphocytes – a type of white blood cell. It is an aggressive form of non-Hodgkin lymphoma. Relapse in DLBCL occurs when the cancer returns after initial treatment while refractory DLBCL is when the disease does not respond to initial treatment. Treatment...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian